Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study

BACKGROUND: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased risk of cardiovascular mortality in this population. In contrast to patients with normal renal functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fellström, Bengt, Zannad, Faiez, Schmieder, Roland, Holdaas, Hallvard, Jardine, Alan, Rose, Helen, Wilpshaar, Wim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175096/
https://www.ncbi.nlm.nih.gov/pubmed/15910680
http://dx.doi.org/10.1186/1468-6708-6-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175096/
https://www.ncbi.nlm.nih.gov/pubmed/15910680
http://dx.doi.org/10.1186/1468-6708-6-9

Ejemplares similares